Facebook  Twitter  Youtube  ISSUU  RSS  Email


Media Contacts

UK
Press Office
press@transparency.org.uk
+ 44 (0)20 3096 7695
Out of hours: Weekends; Weekdays (17.30-21.30): +44 (0)79 6456 0340


Tag Cloud

Allegations anti-bribery anti-corruption summit AntiCorruption anti money laundering bribery BSkyB Cabinet Office companies conflict Corporate Cooperation corrupt capital Corruption corruption in the uk employment film financial secrecy Governance Government health Home Office journalists Letter Leveson Inquiry London Merkel metropolitan police moneylaundering money laundering offshore tax open governance pharmaceuticals PHP police ethics Prime Minister Register of Interests Research safe havens Social Accountability Trustees UK Unexplained Wealth Orders unmask the corrupt UWO vacancies

Twitter

TransparencyUK Bribery isn’t something done by faceless companies, it’s something done by people. Without individual prosecutions… https://t.co/aOL1HJ19Iu
8hreplyretweetfavorite
TransparencyUK Tips for compliance officers during #COVID19 https://t.co/9BgdiMpe5V
10hreplyretweetfavorite
TransparencyUK We can’t cut corners in the race to find a #COVID19 treatment or vaccine to avoid any possibility of data misrepres… https://t.co/8eF4DJGKBb

Stay Informed

Sign up for updates on Transparency International UK's work,corruption news from around the world and fundraising and events updates.

Recent Blog Posts

Search Blog

Guest blogger Shalni Arora looks at corruption’s impact in the healthcare sector, and reflects on what it means for both the achievement of the new development goals as well as universal health coverage.

To ensure research and development of medical treatments becomes more transparent, Transparency International UK is pleased to support the AllTrials campaign calling for all past and present clinical trials to be registered and their results reported.

In February 2014 the UK media claimed that NHS England had, despite prior knowledge, invited a patients group entirely funded by the pharmaceutical industry and headed by a well-known pharmaceutical industry lobbyist to draft a report which could affect future NHS policy. The group is called the Specialised Healthcare Alliance and its Director, John Murray, also heads a lobbying firm whose clients include some of the world’s biggest drug and medical device firms.

Contact Us | Sitemap | Privacy

UK Charity Number 1112842

Transparency International UK is a chapter of